ArticleCureus2025
Prevalence of Seizures in Patients With Tuberculous Meningitis (TBM) and Their Clinical Outcomes.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The diagnosis of tuberculous meningitis (TBM) is challenging, as it requires a high level of clinical suspicion and robust efforts to manage complications. Aim The study focussed on the early detection of seizures and their functional and final outcome with etiological workup radiologically and on lab investigations. Design and methods This was a prospective observational study, in which 100 suspected TBM patients were enrolled based on Lancet consensus criteria at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, from August 2022 to December 2023. Patient's clinical characteristics, TBM severity assessment, CSF analysis, cerebral imaging, and EEG were done. The modified Rankin Score (mRS) assessed clinical outcomes. Results The patients' mean age was 36.12 years, with the majority comprising the female gender (55%). Among the clinical presentations, the most common were fever (88; 88%), headache (60; 60%), altered mental status (AMS) (84; 84%), and seizures on presentation (29; 29%). Of the patients with seizures, 72.4% presented with altered mental status with a p-value of 0.043. Based on the severity of the presentation, 44 (44%) presented in stage II, 35 (35%) presented in clinical stage III, and the rest (21; 21%) in stage I. The GeneXpert Ultra test was positive in 50 (50%) patients for a definitive diagnosis of tuberculous meningitis. On MRI brain, infarcts (42; 42%); hydrocephalus (32; 32%), tuberculomas (31; 31%), and exudates (13; 13%) were seen in patients. Cerebral vasculitic infarcts were found to be an independent predictor of seizures (p 0.01). Out of 29 patients with seizures, 14 patients had an mRS score of 6 and 7 patients had an mRS score of <= 2 at the end of 3 months. Conclusion Vasculitic infarcts in TBM were strongly associated with seizure occurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.